Our latest paper is out! It describes mutations from >32,000 isolates, mapped on the 3D structures of ESX-1 related proteins:
https://t.co/sib8qRCyXi
How much can intensive active case-finding change TB epidemics?
We did two rounds of sputum-based TB screeningโboth an intervention, and a tool for measuring its own impact (intertwined with that of COVID!)โin one community in Kampala, Uganda.
https://t.co/6cAgG1uey1
(1/10)
HTSeq count doesnโt seem to find human cytoplasmic rRNAs in there (ie 18s28s5.8s)?potentially itโs not in the annotation gtf or fasta human genome? HTSseq does find & count mitochondrial 16s and 12s which are also untranslated and not even in the human genome. Anyone have idea?
Hi human genome geeks, question: I would like to have an idea about what the most abundant human gene seqs are in one of my seq libraries. The seq data is derived from serum DNA and RNA and I just need to know which seqs are most prevalent. Any suggestions?
Happy to announce this modelling postdoc opportunity working closely with research partners from Burkina Faso, DRC, @ITMantwerp and @bugwonk. Using genetic data to help improve our understanding of community-level AMR transmission and intervention effects https://t.co/0StNp8ow17
We have been successful at #FWO project ๐ฅณ. If you are looking for an exciting PhD, with international collaborations, have an European Masterโs degree and competitive scores to apply to https://t.co/6cDy0HQ8Ct in March 2023, contact me asap via email; ๐subject: FWO PhD.
Who among you know anyone works with single-cell RNAseq specifically MALBAC amplification protocols for cDNA or any similar method? We are trying to find similarities with virus seq we do and how to improve our protocols. Asking for our post-doc, who wants to pick their brain..
A reminder that I am looking for a postdoc to start in the next couple of months (or later if really need to). Any experience in bioinformatics is welcome, the focus of the project is then somewhat negotiable once related to M tuberculosis and transmission.